Status Epilepticus—Work-Up and Management in Children
暂无分享,去创建一个
[1] Nathan Fountain,et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus. , 2019, The New England journal of medicine.
[2] J. Wheless,et al. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters—a randomized, double‐blind, placebo‐controlled trial , 2019, Epilepsia.
[3] M. Walker,et al. Change in Mortality of Generalized Convulsive Status Epilepticus in High-Income Countries Over Time: A Systematic Review and Meta-analysis. , 2019, JAMA neurology.
[4] T. Loddenkemper,et al. Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus , 2019, Neurology.
[5] C. Gamble,et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial , 2019, The Lancet.
[6] F. Babl,et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial , 2019, The Lancet.
[7] F. Rosenow,et al. Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population‐based study on German health insurance data , 2019, Epilepsia.
[8] N. Gaspard,et al. New onset refractory status epilepticus (NORSE) , 2019, Seizure.
[9] M. Wainwright,et al. Novel drugs and early polypharmacotherapy in status epilepticus , 2019, Seizure.
[10] A. Rotenberg,et al. Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus , 2019, Seizure.
[11] W. Tatum,et al. Pediatric refractory and super-refractory status epilepticus , 2019, Seizure.
[12] Anup D. Patel,et al. A hospital-based study on caregiver preferences on acute seizure rescue medications in pediatric patients with epilepsy: Intranasal midazolam versus rectal diazepam , 2019, Epilepsy & Behavior.
[13] W. Gaillard,et al. Timing and selection of first antiseizure medication in patients with pediatric status epilepticus , 2019, Epilepsy Research.
[14] J. Kapur. Role of NMDA receptors in the pathophysiology and treatment of status epilepticus , 2018, Epilepsia open.
[15] T. Loddenkemper,et al. Estimating the cost of admissions related to convulsive status epilepticus in the United States of America , 2018, Seizure.
[16] H. Goodkin,et al. Hospital Emergency Treatment of Convulsive Status Epilepticus: Comparison of Pathways From Ten Pediatric Research Centers. , 2018, Pediatric neurology.
[17] T. Loddenkemper,et al. Long‐term outcomes of status epilepticus: A critical assessment , 2018, Epilepsia.
[18] H. Goodkin,et al. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus , 2018, Epilepsy Research.
[19] S. Sinha,et al. Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizures , 2018, Annals of neurology.
[20] K. Kapur,et al. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus , 2018, Neurology.
[21] K. Kapur,et al. Association of Time to Treatment With Short-term Outcomes for Pediatric Patients With Refractory Convulsive Status Epilepticus , 2018, JAMA neurology.
[22] L. Lagae,et al. Proposed consensus definitions for new‐onset refractory status epilepticus (NORSE), febrile infection‐related epilepsy syndrome (FIRES), and related conditions , 2018, Epilepsia.
[23] L. Ladino,et al. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review , 2018, Seizure.
[24] Anup D. Patel,et al. Healthcare Utilization Characteristics for Intranasal Midazolam Versus Rectal Diazepam , 2018, Journal of child neurology.
[25] C. Gillberg,et al. Long‐term behavioural outcomes after paediatric convulsive status epilepticus: a population‐based cohort study , 2017, Developmental medicine and child neurology.
[26] C. Gillberg,et al. Long-term prognosis after childhood convulsive status epilepticus: a prospective cohort study. , 2017, The Lancet. Child & adolescent health.
[27] J. Kalita,et al. Comparison of lacosamide versus sodium valproate in status epilepticus: A pilot study , 2017, Epilepsy & Behavior.
[28] K. Kapur,et al. Rescue Medications in Epilepsy Patients: A Family Perspective , 2017, Seizure.
[29] Colin A. Ellis,et al. Timing is everything: Where status epilepticus treatment fails , 2017, Annals of neurology.
[30] A. Al-Asmi,et al. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study , 2017, Seizure.
[31] T. Loddenkemper,et al. Nonintravenous rescue medications for pediatric status epilepticus: A cost‐effectiveness analysis , 2017, Epilepsia.
[32] M. Rogawski,et al. First‐in‐man allopregnanolone use in super‐refractory status epilepticus , 2017, Annals of clinical and translational neurology.
[33] Anup D. Patel,et al. Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals , 2017, Journal of child neurology.
[34] Anup D. Patel,et al. Reduced Emergency Department Utilization by Patients With Epilepsy Using QI Methodology , 2017, Pediatrics.
[35] Tobias Loddenkemper,et al. Refractory status epilepticus in children with and without prior epilepsy or status epilepticus , 2017, Neurology.
[36] É. Azoulay,et al. Hypothermia for Neuroprotection in Convulsive Status Epilepticus. , 2016, The New England journal of medicine.
[37] Yingying Su,et al. Phenobarbital Versus Valproate for Generalized Convulsive Status Epilepticus in Adults: A Prospective Randomized Controlled Trial in China , 2016, CNS Drugs.
[38] C. Avolio,et al. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population , 2016, Seizure.
[39] M Brandon Westover,et al. Therapeutic coma for status epilepticus , 2016, Neurology.
[40] K. Kapur,et al. Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital* , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[41] Y. Ng,et al. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study. , 2016, Pediatric neurology.
[42] J. Wheless,et al. Burden of Seizure Clusters on Patients with Epilepsy and Caregivers (P6.343) , 2016 .
[43] J. F. Kerrigan,et al. Ketogenic diet treatment for pediatric super-refractory status epilepticus , 2016, Seizure.
[44] Ziyu Zhao,et al. A Comparison of Midazolam, Lorazepam, and Diazepam for the Treatment of Status Epilepticus in Children , 2016, Journal of child neurology.
[45] A. Rossetti,et al. Monotherapy or Polytherapy for First-Line Treatment of SE? , 2016, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.
[46] M. Baulac,et al. Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial , 2016, The Lancet Neurology.
[47] D. Treiman,et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society , 2016, Epilepsy currents.
[48] Y. Lee,et al. Intravenous levetiracetam versus phenobarbital in children with status epilepticus or acute repetitive seizures , 2016, Korean journal of pediatrics.
[49] S. Marsch,et al. Anesthetics and Outcome in Status Epilepticus: A Matched Two-Center Cohort Study , 2016, CNS Drugs.
[50] P. Horn,et al. Efficacy of nonvenous medications for acute convulsive seizures , 2015, Neurology.
[51] V. Sabharwal,et al. Propofol–ketamine combination therapy for effective control of super-refractory status epilepticus , 2015, Epilepsy & Behavior.
[52] Simon Shorvon,et al. A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus , 2015, Epilepsia.
[53] W. Löscher. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models , 2015, Epilepsy & Behavior.
[54] P. Satishchandra,et al. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam – Pilot study , 2015, Epilepsy Research.
[55] C. Gurses,et al. Intravenous levetiracetam treatment in status epilepticus: A prospective study , 2015, Epilepsy Research.
[56] Tobias Loddenkemper,et al. Time from convulsive status epilepticus onset to anticonvulsant administration in children , 2015, Neurology.
[57] A. Bhalla,et al. Levetiracetam versus phenytoin in management of status epilepticus , 2015, Journal of Clinical Neuroscience.
[58] T. Loddenkemper,et al. Pediatric status epilepticus management , 2014, Current opinion in pediatrics.
[59] W. Gaillard,et al. Pediatric status epilepticus: identification and evaluation , 2014, Current opinion in pediatrics.
[60] M. Rogawski,et al. Pediatric super‐refractory status epilepticus treated with allopregnanolone , 2014, Annals of neurology.
[61] R. Tasker,et al. Intensive Care Treatment of Uncontrolled Status Epilepticus in Children: Systematic Literature Search of Midazolam and Anesthetic Therapies* , 2014, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[62] R. Griggs,et al. The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease , 2014, Neurology.
[63] J. Chamberlain,et al. Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. , 2014, JAMA.
[64] Shumei S. Sun,et al. Emergency management of febrile status epilepticus: Results of the FEBSTAT study , 2014, Epilepsia.
[65] S. Shorvon,et al. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies , 2014, Seizure.
[66] F. Rincon,et al. The Epidemiology of Status Epilepticus in the United States , 2014, Neurocritical Care.
[67] R. Berg,et al. Electrographic status epilepticus and long-term outcome in critically ill children , 2014, Neurology.
[68] Shumei S. Sun,et al. Hippocampal sclerosis after febrile status epilepticus: The FEBSTAT study , 2014, Annals of neurology.
[69] I. Valencia,et al. Efficacy of Lacosamide as Adjunctive Therapy in Children With Refractory Epilepsy , 2014, Journal of child neurology.
[70] D. Goldstein,et al. Gaps and opportunities in refractory status epilepticus research in children: A multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG) , 2013, Seizure.
[71] C. Clark,et al. Hippocampal volume loss following childhood convulsive status epilepticus is not limited to prolonged febrile seizures , 2013, Epilepsia.
[72] J. Szaflarski,et al. Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study , 2013, Epilepsia.
[73] K. Sawanyawisuth,et al. The efficacy of intravenous sodium valproate and phenytoin as the first-line treatment in status epilepticus: a comparison study , 2013, BMC Neurology.
[74] D. Naylor,et al. Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus , 2013, Neurobiology of Disease.
[75] Mohammad Reza Najafi,et al. A Comparative Assessment the Efficacy of Intravenous Infusion of Sodium Valproate and Phenytion in the Treatment of Status Epilepticus , 2013, International journal of preventive medicine.
[76] R. Tasker,et al. Pediatric intensive care treatment of uncontrolled status epilepticus. , 2013, Critical care clinics.
[77] M. Falip,et al. Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: A multicentric prospective study , 2013, Seizure.
[78] M. Sperling,et al. Treatment of Status Epilepticus: An International Survey of Experts , 2013, Neurocritical Care.
[79] N. Khosroshahi,et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. , 2012, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[80] S. Shorvon,et al. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. , 2012, Brain : a journal of neurology.
[81] J. Kapur,et al. O Brother, Wherefore Are Thou? Calcium-Permeable AMPA Receptors Make an Appearance in Adult Status Epilepticus , 2013, Epilepsy currents.
[82] M. Mastrangelo,et al. Diagnostic work-up and therapeutic options in management of pediatric status epilepticus , 2012, World Journal of Pediatrics.
[83] Paul M. Vespa,et al. Guidelines for the Evaluation and Management of Status Epilepticus , 2012, Neurocritical Care.
[84] R. Conwit,et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. , 2012, New England Journal of Medicine.
[85] Andrea O Rossetti,et al. Management of refractory status epilepticus in adults: still more questions than answers , 2011, The Lancet Neurology.
[86] R. Scott,et al. Death within 8 years after childhood convulsive status epilepticus: a population-based study. , 2011, Brain : a journal of neurology.
[87] Simon Shorvon,et al. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. , 2011, Brain : a journal of neurology.
[88] H. Goodkin,et al. Treatment of Pediatric Status Epilepticus , 2011, Current treatment options in neurology.
[89] B. Burnand,et al. Second‐line status epilepticus treatment: Comparison of phenytoin, valproate, and levetiracetam , 2011, Epilepsia.
[90] E. Hilmas,et al. Levetiracetam for the treatment of pediatric status epilepticus: A case series , 2011, Journal of Pediatric Neurology.
[91] J. S. Leeder,et al. Effects of Valproic Acid on Organic Acid Metabolism in Children: A Metabolic Profiling Study , 2011, Clinical pharmacology and therapeutics.
[92] C. Kellinghaus,et al. Intravenous lacosamide for treatment of status epilepticus , 2011, Acta neurologica Scandinavica.
[93] J. Miró,et al. Efficacy of intravenous levetiracetam as an add-on treatment in status epilepticus: A multicentric observational study , 2011, Seizure.
[94] A. McGonigal,et al. Generalized convulsive status epilepticus management in adults: A cohort study with evaluation of professional practice , 2010, Epilepsia.
[95] Terrie Inder,et al. Neonatal status epilepticus. , 2010, Seminars in pediatric neurology.
[96] M. Manfredi,et al. Intravenous Levetiracetam as first‐line treatment of status epilepticus in the elderly , 2010, Acta neurologica Scandinavica.
[97] S. Krishnamurthy,et al. Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial. , 2010, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[98] N. Watemberg,et al. A Suggested Approach to the Etiologic Evaluation of Status Epilepticus in Children: What to Seek After the Usual Causes Have Been Ruled Out , 2010, Journal of child neurology.
[99] D. Naylor,et al. Molecular basis of self‐sustaining seizures and pharmacoresistance during status epilepticus: The receptor trafficking hypothesis revisited , 2009, Epilepsia.
[100] J. Pascual,et al. Experience with Intravenous Levetiracetam in Status Epilepticus , 2009, CNS drugs.
[101] K. Sawanyawisuth,et al. Predictors and prognosis of status epilepticus treated with intravenous sodium valproate. , 2009, Epileptic disorders : international epilepsy journal with videotape.
[102] M. Müller,et al. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam , 2009, Epilepsy & Behavior.
[103] C. Kellinghaus,et al. Intravenous levetiracetam as treatment for status epilepticus , 2009, Journal of Neurology.
[104] R. Scott,et al. Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study , 2008, The Lancet Neurology.
[105] W. Oertel,et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[106] R. Chandra,et al. Randomized study of intravenous valproate and phenytoin in status epilepticus , 2007, Seizure.
[107] L. Gjerstad,et al. Valproate is an effective, well‐tolerated drug for treatment of status epilepticus/serial attacks in adults , 2007, Acta neurologica Scandinavica. Supplementum.
[108] A. Rossetti. Sodium valproate vs phenytoin in status epilepticus: A pilot study , 2007, Neurology.
[109] S. Ashwal,et al. Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review) , 2006, Neurology.
[110] R. Scott,et al. Outcome of paediatric convulsive status epilepticus: a systematic review , 2006, The Lancet Neurology.
[111] J. Kalita,et al. Sodium valproate vs phenytoin in status epilepticus: A pilot study , 2006, Neurology.
[112] Rod C Scott,et al. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study , 2006, The Lancet.
[113] Y. Nakajima,et al. A Prospective, Randomized Study , 2006 .
[114] A. Auvinen,et al. Treatment delay and the risk of prolonged status epilepticus , 2005, Neurology.
[115] D. Naylor,et al. Trafficking of GABAA Receptors, Loss of Inhibition, and a Mechanism for Pharmacoresistance in Status Epilepticus , 2005, The Journal of Neuroscience.
[116] H. Goodkin,et al. Status Epilepticus Increases the Intracellular Accumulation of GABAA Receptors , 2005, The Journal of Neuroscience.
[117] S. van Gestel,et al. Propofol and thiopental for refractory status epilepticus in children , 2005, Neurology.
[118] J. Perlin,et al. Estimating the economic burden of status epilepticus to the health care system , 2005, Seizure.
[119] A. Marmarou,et al. Time to treatment in prolonged seizure episodes , 2004, Epilepsy & Behavior.
[120] K. Yu,et al. Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures , 2003, Epilepsia.
[121] R. Koul,et al. Eight-Year Study of Childhood Status Epilepticus: Midazolam Infusion in Management and Outcome , 2002, Journal of child neurology.
[122] Stephen Maren,et al. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus , 2002, Epilepsy Research.
[123] P. Garcia,et al. Incidence and mortality of generalized convulsive status epilepticus in California , 2002, Neurology.
[124] W. Hauser,et al. Long-term mortality after a first episode of status epilepticus , 2002, Neurology.
[125] Jan Claassen,et al. Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic Review , 2002, Epilepsia.
[126] M R Segal,et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. , 2001, The New England journal of medicine.
[127] D. Gilbert. Practice parameter: Evaluating a first nonfebrile seizure in children: Report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society , 2001, Neurology.
[128] S. Moss,et al. Constitutive Endocytosis of GABAA Receptors by an Association with the Adaptin AP2 Complex Modulates Inhibitory Synaptic Currents in Hippocampal Neurons , 2000, The Journal of Neuroscience.
[129] P Jallon,et al. Incidence of status epilepticus in French-speaking Switzerland , 2000, Neurology.
[130] S. Ashwal,et al. Practice parameter: Evaluating a first nonfebrile seizure in children , 2000, Neurology.
[131] W. Rosenfeld,et al. Treating repetitive seizures with a rectal diazepam formulation , 1998, Neurology.
[132] B. Uthman,et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. , 1998, The New England journal of medicine.
[133] R. Kuzniecky,et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. , 1998, The New England journal of medicine.
[134] R. Macdonald,et al. Rapid Seizure-Induced Reduction of Benzodiazepine and Zn2+ Sensitivity of Hippocampal Dentate Granule Cell GABAA Receptors , 1997, The Journal of Neuroscience.
[135] John Keith Brown,et al. NASAL RATHER THAN RECTAL BENZODIAZEPINES IN THE MANAGEMENT OF ACUTE CHILDHOOD SEIZURES? , 1996, Developmental medicine and child neurology.
[136] W. Hauser,et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia , 1996, Neurology.
[137] J. Golding,et al. Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. , 1993, BMJ.
[138] S. Moshé,et al. Low morbidity and mortality of status epilepticus in children. , 1989, Pediatrics.
[139] D. Treiman,et al. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam , 1988, Experimental Neurology.
[140] K. Rawal,et al. Status epilepticus. , 1985, Critical care clinics.
[141] Corsellis Ja,et al. Neuropathology of status epilepticus in humans. , 1983, Advances in neurology.
[142] C. Bruton,et al. Neuropathology of status epilepticus in humans. , 1983, Advances in neurology.
[143] M. Aminoff,et al. Status epilepticus: Causes, clinical features and consequences in 98 patients , 1980 .
[144] B. Meldrum,et al. Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons. , 1973, Archives of neurology.
[145] B. Meldrum,et al. Physiology of status epilepticus in primates. , 1973, Archives of neurology.
[146] B. Meldrum,et al. Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. , 1973, Archives of neurology.
[147] R. Norman. The Neuropathology of Status Epilepticus , 1964, Medicine, science, and the law.